Christobel Selecky Sells $1.44M of ImmunityBio Inc (IBRX) — SEC Form 4, Jul 07, 2026
Open-Market Net Sale · SEC Form 4
−$1,439,066
10b5-1 Plan
Equity Position
159K sh
159,478 → 159,478
Filing Lag
3 business days
late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Christobel Selecky CIK 0001849739 |
Director
|
Christobel Selecky at ImmunityBio Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$2,997,932
More from this insider at ImmunityBio Inc
| 2026-07-01 | Sell | -$871,216 | View |
| 2026-06-11 | Award | — | View |
| 2026-02-25 | Sell | -$250,000 | View |
| 2026-01-22 | Sell | -$437,650 | View |
| 2025-06-20 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-07-01 | M - Exercise 10b5-1 | 35,064 A | $2.98 | +$104,491 | 35,064 | Direct |
| Common Stock | 2026-07-01 | M - Exercise 10b5-1 | 124,414 A | $2.99 | +$371,998 | 159,478 | Direct |
| Common StockF1F2 | 2026-07-01 | S - Sale 10b5-1 | 159,478 D | $9.02 | -$1,439,066 | 0 | Direct |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.98 | 2026-07-01 | M - Exercise 10b5-1 | 35,064 D | $0.00 | 2032-06-14 | 35,064 Common Stock | Direct |
| Stock Option (right to buy) | $2.99 | 2026-07-01 | M - Exercise 10b5-1 | 124,414 D | $0.00 | 2033-06-13 | 124,414 Common Stock | Direct |
Footnotes (2)
- F1
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026. Show more
- F2
- Represents the weighted average share price of an aggregate total of 159,478 shares sold in the price range of $9.00 to $9.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Show more
Related filings at ImmunityBio Inc
Institutional Holders
13F holders · Jun 30, 2026
404
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $298M
- State Street Corporation $187M
- Vanguard Portfolio Management Llc $156M
5%+ Holders · 13D/G
1 filer
-
Cambridge Equities, LP 64.8%
Other insiders at ImmunityBio Inc
-
Barry J. Simon -$269K
-
Cheryl Cohen -$851K
-
Cheryl Cohen -$1.25M
-
Barry J. Simon -$197K
GET /v1/forms/4/0001849739-26-000014
API docs
View Original SEC Filing